High Dose Chemotherapy and Autologous Transplant for Breast Cancer
NCT00186641 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2007-07-11
Summary
To determine survival outcomes for patients with chemosensitive brest cancer after treatment with high dose chemotherapy
Conditions
- Graft vs Host Disease
Interventions
- PROCEDURE
-
high dose chemo and auto hematopoietic cell transplant
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Ginna Laport, MD · Stanford University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Completion
- 2005-03-31
Countries
- United States
Study Locations
More Related Trials
-
High-dose Chemotherapy With Hematopoietic Stem-cell Rescue for High-risk Breast Cancer: Long-term Follow-up
NCT03087409 ·Status: COMPLETED
-
Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer
NCT02101385 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer
NCT00020722 ·Status: TERMINATED ·Phase: PHASE2
-
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer
NCT02003209 ·Status: COMPLETED ·Phase: PHASE3
-
Chemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 Inhibitor
NCT06996093 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy
NCT00001440 ·Status: COMPLETED ·Phase: PHASE1
-
Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer
NCT00003680 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Neoadjuvant Chemoradiation on Pathologic Complete Response Rates in Locally Advanced Breast Cancer Patients
NCT06631066 ·Status: COMPLETED ·Phase: NA
-
High Dose Rate Intracavitary Brachytherapy as the Sole Method of Radiation Therapy for Breast Carcinoma
NCT00165581 ·Status: TERMINATED ·Phase: NA
-
S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
NCT00002772 ·Status: TERMINATED ·Phase: PHASE3
-
Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors
NCT00851110 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer
NCT00038402 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
NCT00021255 ·Status: COMPLETED ·Phase: PHASE3
-
Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast Cancer
NCT00365365 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer
NCT00003972 ·Status: COMPLETED ·Phase: PHASE3
-
Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer
NCT00136539 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
NCT00353483 ·Status: RECRUITING
-
Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer
NCT01334021 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
NCT01275677 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer
NCT07220135 ·Status: RECRUITING ·Phase: PHASE2
-
Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer
NCT00872625 ·Status: COMPLETED ·Phase: PHASE1
-
A Multicenter Prospective Cohort Study of Adjuvant Therapy for BRCA1/2 Mutated Hormone Receptor-positive HER2-negative Early High-risk Breast Cancer
NCT06791161 ·Status: ENROLLING_BY_INVITATION
-
Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients
NCT00270894 ·Status: COMPLETED ·Phase: PHASE2
-
Tocotrienol in Combination With Neoadjuvant Chemotherapy for Women With Breast Cancer
NCT02909751 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer
NCT00017095 ·Status: COMPLETED ·Phase: PHASE3